-
Rituximab, sold
under the
brand name
Rituxan among others, is a
monoclonal antibody medication used to
treat certain autoimmune diseases and
types of...
- corticosteroids.
Sometimes the
chimeric anti-CD20
monoclonal antibody,
rituximab, is
added to this
treatment regimen to form the R-CHOP regimen. R-miniCHOP...
- of t-FL (e.g., the
addition to
standard chemotherapy of
agents such as
rituximab) have
improved overall survival times.
These newer regimens may also delay...
-
bendamustine with
rituximab.
Second line
treatment may
include fludarabine,
combined with
cyclophosphamide and/or mitoxantrone,
usually with
rituximab. Cladribine...
- 90% to less than 20%. Immunosuppressants, such as glucocorticoids, and
rituximab may also be used.
Platelet transfusions are
generally not recommended...
- as
rituximab or
cyclophosphamide and high-dose
corticosteroids to
control the
symptoms of the disease, and azathioprine, methotrexate, or
rituximab to...
- such as
rituximab,
which are
increasingly being used as first-line treatment. In the
summer of 2018, the FDA
granted full
approval to
rituximab for this...
- are non-responsive to the
standard treatment. They are
responsive to
Rituximab instead. Also some
cases of
combined central and
peripheral demyelination...
- use corticosteroids.[citation needed] The anti-CD20
monoclonal antibody rituximab has been
found to be
effective in
treating some
otherwise refractory cases...
-
Ocrelizumab binds to an
epitope that
overlaps with the
epitope to
which rituximab binds. It is
administered by
intravenous infusion. The fixed-dose combination...
